FNDR-20123
FNDR-20123 is a potent, dual-targeting HDAC inhibitor effective against both Plasmodium falciparum and human HDACs, with particular nanomolar potency against HDAC1, HDAC2, HDAC3, and HDAC6. This compound serves as a valuable research tool for investigating epigenetic mechanisms in malaria and oncology, supporting both in vitro enzymatic assays and cellular research.
Product Specifications
Field of Research
Epigenetics & Chromatin, Infectious Disease & Virology, Molecular Biology
Molecular Formula
C21H24ClN5O2
Molecular Weight
413.9
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15352159 1 Vial
Lentiviral human ZNF385C shRNA (UAS) - Lentiviral human ZNF385C shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 
ASE-9110 1 vial (1 x 10^6)
iPSC (iPSC from Blood Cells; Feale, Master Lines for Neural Differentiation) *Academic Price
Sign In for Pricing
View Details